• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US PFC*SIGMA/OV/DOME PAT 3PEG,41; SIGMA KNEE PRIMARY : KNEE PATELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US PFC*SIGMA/OV/DOME PAT 3PEG,41; SIGMA KNEE PRIMARY : KNEE PATELLA Back to Search Results
Model Number 96-0103
Device Problems Naturally Worn (2988); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 06/09/2023
Event Type  Injury  
Event Description
Clinical adverse event received for recurrent hemarthrosis.Event is serious and is considered moderate.Event is possibly related to both device and procedure.Date of implant: (b)(6) 2014.Date of revision: unk.Date of event: (b)(6) 2023.(left knee).Treatment: revision; revised components not specified.
 
Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Due to new information noting that only the insert was revised, the previously reported tibial tray, femoral component, cement, and patella will now be not reportable as the surgeon elected not revise them.It is reasonable to conclude those components that were not revised were not part of the reason for the revision.Due to this, depuy synthes joint reconstruction considers the device on this report to be not reportable as there is no allegation of deficiency or patient harm, additional follow up is being conducted.Further updates will only be provided if additional information is received that changes the regulatory determination.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: the device associated with this report was not returned to depuy synthes for evaluation.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: added: b1 (product problem), b5.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected: h1 (type of reportable event), h6 medical device problem code.
 
Event Description
Operative notes received.On (b)(6) 2014, the patient underwent a left primary knee arthroplasty with no complications.On (b)(6) 2023, the patient underwent a revision of the tibial insert secondary to recurrent hemarthrosis.Prior to surgery, he had multiple episodes of nontraumatic swelling and pain.He was aspirated 3 times prior to the revision.Intraoperatively, hypertrophic synovium was identified due to possible impingement between the components causing bleeding.Posterolateral flexion instability was also identified.There was also lateral instability requiring release of the superficial mcl and an upsize of the insert.A wear stripe was identified on the patella but it was not revised.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
SIGMA KNEE PRIMARY : KNEE PATELLA
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
DEPUY ORTHOPAEDICS, INC. 1818910
700 orthopaedic dr.
warsaw IN 46581 0988
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key17154409
MDR Text Key317450543
Report Number1818910-2023-12462
Device Sequence Number1
Product Code JWH
UDI-Device Identifier10603295232636
UDI-Public10603295232636
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P830055
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 06/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number96-0103
Device Catalogue Number960103
Device Lot NumberD14063583
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/08/2023
Initial Date FDA Received06/19/2023
Supplement Dates Manufacturer Received06/14/2023
06/26/2023
08/03/2023
Supplement Dates FDA Received06/26/2023
07/14/2023
08/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/09/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DEPUY CMW 1 40G; MBT CEM KEEL TIB TRAY SZ5; PFC*SIGMA C/R NPOR FEM LT SZ5; SIG RP AOX CRV INS SZ5 10
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexMale
Patient Weight86 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-